Gynecology
Hysteroscopy with sampling of the uterine lining
CPT 58558
$3,484 - $7,016
from 3 insurers · median $5,154
52 Medicare claims in Level 4 Gynecologic Procedures (CMS 2024)
Ardent Health Services · Albuquerque, NM
4 of 5
CMS star rating
162
Beds
9,103
Inpatient discharges a year
$242.5M
Net patient revenue a year
33
In-network payers
Lovelace Women S Hospital is a 162-bed proprietary hospital in Albuquerque, NM, affiliated with Ardent Health Services. Below you'll find publicly disclosed negotiated rates and facility details, including 33 in-network payers and 271 disclosed rate categories.
The 24 services Lovelace Women S Hospital most likely performs, ranked by likely volume and what it is paid. Each service names one insurer. * marks hidden insurer names; A, B and C rank the remaining rates from low to high and reset for each service.
Book a demo to see hidden insurer names, more payer rates, and hospital data, or start a free trial.
Gynecology
CPT 58558
$3,484 - $7,016
from 3 insurers · median $5,154
52 Medicare claims in Level 4 Gynecologic Procedures (CMS 2024)
Childbirth · Inpatient
MS-DRG 807
$8,805 - $10,412
from 3 insurers · median $9,344
CMS lists this service as CPT 59400, the obstetrician's global fee. The hospital bills the delivery stay as MS-DRG 807, so these are facility case rates.
Hospital reports neonatal nursery services to CMS
Medicine & Surgery
CPT 47562
$5,160 - $23,337
from 3 insurers · median $16,014
137 Medicare claims in Level 1 Laparoscopy and Related Services (CMS 2024)
Childbirth · Inpatient
MS-DRG 788
$11,862 - $13,242
from 3 insurers · median $13,122
CMS lists this service as CPT 59510, the obstetrician's global fee. The hospital bills the delivery stay as MS-DRG 788, so these are facility case rates.
Hospital reports neonatal nursery services to CMS
Gynecology
CPT 58571
$7,142 - $35,229
from 3 insurers · median $16,014
59 Medicare claims in Level 2 Laparoscopy and Related Services (CMS 2024)
Digestive procedures
CPT 47563
$6,243 - $35,229
from 3 insurers · median $16,014
137 Medicare claims in Level 1 Laparoscopy and Related Services (CMS 2024)
Digestive procedures
CPT 49650
$4,939 - $16,014
from 3 insurers · median $5,970
137 Medicare claims in Level 1 Laparoscopy and Related Services (CMS 2024)
Medicine & Surgery
CPT 55866
$5,160 - $31,616
from 3 insurers · median $22,845
59 Medicare claims in Level 2 Laparoscopy and Related Services (CMS 2024)
CT imaging
CPT 74177
$824 - $6,163
from 3 insurers · median $862
Common here, based on CMS Medicare volume
Digestive procedures
CPT 43239
$1,584 - $3,548
from 4 insurers · median $3,274
Common here, based on CMS Medicare volume
Cardiology and vascular testing
CPT 93306
$1,016 - $1,614
from 3 insurers · median $1,282
Common here, based on CMS Medicare volume
Urology
CPT 50590
$5,408 - $34,784
from 3 insurers · median $16,014
55 Medicare claims in Level 4 Urology and Related Services (CMS 2024)
CT imaging
CPT 70450
$236 - $599
from 3 insurers · median $566
Common here, based on CMS Medicare volume
Digestive procedures
CPT 45380
$1,629 - $3,548
from 4 insurers · median $3,096
Common here, based on CMS Medicare volume
Childbirth · Inpatient
MS-DRG 807
$8,805 - $10,412
from 3 insurers · median $9,344
CMS lists this service as CPT 59610, the obstetrician's global fee. The hospital bills the delivery stay as MS-DRG 807, so these are facility case rates.
Hospital reports neonatal nursery services to CMS
Nuclear imaging
CPT 78452
$667 - $15,648
from 4 insurers · median $4,105
Common here, based on CMS Medicare volume
Medicine & Surgery · Inpatient
MS-DRG 460
$43,032 - $55,663
from 2 insurers · median $49,348
Hospital reports orthopedic surgery services to CMS
Medicine & Surgery
CPT 66984
$4,637 - $7,016
from 3 insurers · median $5,160
Typical for a hospital with this service line
Mammography
CPT 77067
$192 - $393
from 3 insurers · median $204
Common here, based on CMS Medicare volume
Orthopedics and pain
CPT 20610
$1,391 - $2,063
from 3 insurers · median $1,704
Common here, based on CMS Medicare volume
Medicine & Surgery · Inpatient
MS-DRG 473
$30,320 - $40,914
from 3 insurers · median $38,460
Hospital reports orthopedic surgery services to CMS
CT imaging
CPT 71275
$394 - $3,404
from 3 insurers · median $770
Common here, based on CMS Medicare volume
Gynecology
CPT 57288
$5,160 - $12,114
from 3 insurers · median $5,379
22 Medicare claims in Level 5 Gynecologic Procedures (CMS 2024)
CT imaging
CPT 74176
$525 - $657
from 2 insurers · median $591
Common here, based on CMS Medicare volume
Median rate as a percent of Medicare across the outpatient services above, and how many services sit above or below the same insurer's median at nearby hospitals. * marks hidden insurer names. These table labels track the same insurers across services; the labels on each service card reset.
| Insurer | Services | Median % of Medicare | Above nearby | Below nearby |
|---|---|---|---|---|
| Insurer A* | 8 | 427% | 0 | 0 |
| Insurer B* | 18 | 291% | 0 | 0 |
| Insurer C* | 23 | 237% | 0 | 0 |
| Insurer D* | 24 | 182% | 0 | 0 |
How we chose these services: 8 appear in this hospital's own Medicare claims, 10 are common here based on CMS Medicare volume, and 6 are typical for the service lines it reports to CMS. Rates come from insurer and hospital price transparency files as of October 2026. Rates under a quarter of Medicare or over 20 times Medicare are left out as likely physician-fee rows or file errors. Book a demo to see all 300 CMS shoppable services for Lovelace Women S Hospital, or start a free trial.
Acceptance varies by plan and service. Confirm coverage with your insurer or the hospital's billing department.





Quality
4 of 5 stars
Doctors and services
Accredited by The Joint Commission
Finances
$242.5M net patient revenue
Ownership and leadership
Owned by Ahp Health Partners, Inc
The employer identification numbers (EINs) health plans and networks list for Lovelace Women S Hospital in the in-network rate files they publish, with the organization NPIs billed under each.
| Tax ID (EIN) | Plans and networks listing it | Organization NPIs |
|---|---|---|
| 85-0327237Lovelace Regional Hospital-Roswell | 49Aetna, Cigna, United Healthcare (incl Optum, Rocky Mountain, Health Plan of Nevada, Sierra Health), Allied Benefit Systems, Ambetter and 44 more | 1972878361 Lovelace Health System LLC1306914213 Lovelace Health System LLC1982799375 Lovelace Health System LLCand 39 more |
Source: PayerPrice analysis of insurers' Transparency in Coverage in-network files. An EIN can cover several hospitals and clinics in a health system, and insurers sometimes list other organizations' NPIs under it.
4701 Montgomery Boulevard Ne, Albuquerque, NM 87109
(505) 727-7805
How Lovelace Women S Hospital compares with other US facilities on the measures CMS publishes, mostly from Medicare patients.
Overall star rating
4 of 5
Higher than 58% of US hospitals
Combines death rates, safety, readmissions, patient experience and timely care
Death rates
No different on 3 measures
0 better, 3 no different, 0 worse than the US rate
Deaths within 30 days, such as after a heart attack, pneumonia or stroke
Safety
Better on 1 of 5 measures
1 better, 4 no different, 0 worse than the US rate
Infections, surgical complications and other harm in the hospital
Readmissions
Better on 1 of 5 measures
1 better, 4 no different, 0 worse than the US rate
Patients back in the hospital or ER soon after leaving
Patient survey rating
2 of 5
Lower than 81% of US hospitals
From the HCAHPS survey of recent inpatients
Would definitely recommend
65%
Lower than 73% of US hospitals
US median: 71%
Surveyed patients who would definitely recommend the hospital
Hospital-acquired condition penalty
Not penalized
Not among the worst-performing 25%
Medicare cuts payments 1% for the worst-performing 25% of hospitals on infections and injuries acquired in the hospital
Serious complications (PSI 90)
0.92
Lower than 67% of US hospitals
US median: 0.96
Risk-adjusted composite of complications such as bedsores, falls with hip fracture and blood clots after surgery; lower is better
Time in the ER before going home
205 min
Higher than 83% of US hospitals
US median: 148 min
Median minutes from arrival to leaving for ER patients who were sent home; lower is better
Sepsis care
71%
Higher than 63% of US hospitals
US median: 65%
Patients with severe sepsis or septic shock who got every step of the recommended early treatment; higher is better
| Measure | Result | Period |
|---|---|---|
| Overall star ratingCMS: Overall hospital quality star rating | 4 of 5 | |
| Death rates | No different on 3 measures | |
| Safety | Better on 1 of 5 measures | |
| Readmissions | Better on 1 of 5 measures | |
| Patient survey ratingCMS: Summary star rating | 2 of 5 | 2024-10-01 to 2025-09-30 |
| Would definitely recommendCMS: "YES", patients would definitely recommend the hospital | 65% | 2024-10-01 to 2025-09-30 |
| Hospital-acquired condition penaltyCMS: HAC Reduction Program payment reduction | Not penalized | 2026 |
| Serious complications (PSI 90)CMS: Patient safety and adverse events composite (PSI 90) | 0.92 | 2022-07-01 to 2024-06-30 |
| Time in the ER before going homeCMS: Average (median) time patients spent in the emergency department before leaving from the visit, excluding patients transferred to another facility or psychiatric care/mental health patients. A lower number of minutes is better | 205 min | 2024-10-01 to 2025-09-30 |
| Sepsis careCMS: Appropriate care for severe sepsis and septic shock | 71% | 2024-10-01 to 2025-09-30 |
Source: CMS Provider Data Catalog, released 2026-08-13. US comparisons rank this facility among every facility CMS reports for each measure. See Medicare Care Compare.
How Medicare adjusts Lovelace Women S Hospital's inpatient payments for its readmissions, quality and cost results.
-0.05% on Medicare payments
Readmissions penalty
Hospital Readmissions Reduction Program adjustment for excess readmissions, as estimated in the FY 2027 IPPS final rule.
+0.88% on Medicare payments
Value-based purchasing
Hospital Value-Based Purchasing bonus or reduction for quality and cost, as estimated in the FY 2027 IPPS final rule.
Source: CMS IPPS final rule Impact File (FY 2027).
Each result CMS publishes for Lovelace Women S Hospital, beside the US median and the average of NM hospitals. The rank says what share of US hospitals the result is better or worse than; counts and confidence limits are not ranked.
Risk-adjusted 30-day death rates and surgical complications; lower is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Rate of complications for hip/knee replacement patients2023-04-01 to 2025-03-31 | Not Available | 4.263 | |||
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality Rate2024-07-01 to 2025-06-30 · 836 cases | 3.5 | 3.9 | 4.105 | Better than 74% of US hospitals | |
| Death rate for heart attack patients2022-07-01 to 2025-06-30 | Not Available | 11.59 | |||
| Death rate for CABG surgery patients2022-07-01 to 2025-06-30 | Not Available | 2.225 | |||
| Death rate for COPD patients2022-07-01 to 2025-06-30 | Not Available | 9.143 | |||
| Death rate for heart failure patients2022-07-01 to 2025-06-30 · 44 cases | 9.4 | 11 | 11.32 | Better than 80% of US hospitals | |
| Death rate for pneumonia patients2022-07-01 to 2025-06-30 · 85 cases | 13.1 | 15.2 | 15.71 | Better than 80% of US hospitals | |
| Death rate for stroke patients2023-07-01 to 2025-06-30 · 27 cases | 11.9 | 11.6 | 12.8 | Worse than 54% of US hospitals | |
| Pressure ulcer rate2022-07-01 to 2024-06-30 · 811 cases | 0.45 | 0.51 | 0.8262 | No Different Than the National Rate | Better than 59% of US hospitals |
| Death rate among surgical inpatients with serious treatable complications2022-07-01 to 2024-06-30 | Not Available | 175 | Number of Cases Too Small | ||
| Iatrogenic pneumothorax rate2022-07-01 to 2024-06-30 · 1,121 cases | 0.2 | 0.2 | 0.2042 | No Different Than the National Rate | Better than 46% of US hospitals |
| In-hospital fall-associated fracture rate2022-07-01 to 2024-06-30 · 1,096 cases | 0.26 | 0.27 | 0.2846 | No Different Than the National Rate | Better than 54% of US hospitals |
| Postoperative hemorrhage or hematoma rate2022-07-01 to 2024-06-30 · 242 cases | 2.2 | 2.29 | 2.4 | No Different Than the National Rate | Better than 66% of US hospitals |
| Postoperative acute kidney injury requiring dialysis rate2022-07-01 to 2024-06-30 · 95 cases | 1.63 | 1.63 | 1.733 | No Different Than the National Rate | Better than 50% of US hospitals |
| Postoperative respiratory failure rate2022-07-01 to 2024-06-30 · 108 cases | 7.98 | 8.88 | 9.83 | No Different Than the National Rate | Better than 71% of US hospitals |
| Perioperative pulmonary embolism or deep vein thrombosis rate2022-07-01 to 2024-06-30 · 263 cases | 3.58 | 3.4 | 3.584 | No Different Than the National Rate | Worse than 66% of US hospitals |
| Postoperative sepsis rate2022-07-01 to 2024-06-30 · 104 cases | 5.66 | 5.105 | 5.607 | No Different Than the National Rate | Worse than 71% of US hospitals |
| Postoperative wound dehiscence rate2022-07-01 to 2024-06-30 · 76 cases | 1.74 | 1.72 | 1.854 | No Different Than the National Rate | Worse than 59% of US hospitals |
| Abdominopelvic accidental puncture or laceration rate2022-07-01 to 2024-06-30 · 370 cases | 0.97 | 1.02 | 1.033 | No Different Than the National Rate | Better than 67% of US hospitals |
Unplanned returns to a hospital after a stay or an outpatient procedure; lower is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Hospital return days for heart attack patients2022-07-01 to 2025-06-30 | Not Available | 2.345 | |||
| Hospital return days for heart failure patients2022-07-01 to 2025-06-30 · 42 cases | -46.8 | 1.25 | -3.923 | Better than 96% of US hospitals | |
| Hospital return days for pneumonia patients2022-07-01 to 2025-06-30 · 95 cases | -19 | 3.85 | -4.245 | Better than 79% of US hospitals | |
| Hybrid Hospital-Wide All-Cause Readmission Measure (HWR)2024-07-01 to 2025-06-30 | Not Available | ||||
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)2022-01-01 to 2024-12-31 · 1,007 cases | 12.8 | 12.9 | 13.19 | No Different Than the National Rate | Better than 55% of US hospitals |
| Rate of inpatient admissions for patients receiving outpatient chemotherapy2024-01-01 to 2024-12-31 | Not Available | 10.42 | Number of Cases Too Small | ||
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy2024-01-01 to 2024-12-31 | Not Available | 5.467 | Number of Cases Too Small | ||
| Ratio of unplanned hospital visits after hospital outpatient surgery2024-01-01 to 2024-12-31 · 502 cases | 1.6 | 1 | 1.062 | Worse than expected | Worse than 99% of US hospitals |
| Acute Myocardial Infarction (AMI) 30-Day Readmission Rate2023-07-01 to 2025-06-30 | Not Available | 14.15 | |||
| Rate of readmission for CABG2023-07-01 to 2025-06-30 | Not Available | 11.06 | |||
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patients2023-07-01 to 2025-06-30 · 47 cases | 19.1 | 19.8 | 19.53 | Better than 81% of US hospitals | |
| Heart failure (HF) 30-Day Readmission Rate2023-07-01 to 2025-06-30 · 79 cases | 20.5 | 21.3 | 21.13 | Better than 75% of US hospitals | |
| Rate of readmission after hip/knee replacement2023-07-01 to 2025-06-30 · 25 cases | 5.6 | 5.8 | 5.589 | Better than 58% of US hospitals | |
| Pneumonia (PN) 30-Day Readmission Rate2023-07-01 to 2025-06-30 · 185 cases | 16.3 | 17.2 | 17 | Better than 86% of US hospitals |
Standardized infection ratios (1 is the US baseline) and the counts behind them; lower is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Central Line Associated Bloodstream Infection (ICU + select Wards): Lower Confidence Limit2024-10-01 to 2025-09-30 | 0.03 | 0.172 | 0.411 | No Different than National Benchmark | |
| Central Line Associated Bloodstream Infection (ICU + select Wards): Upper Confidence Limit2024-10-01 to 2025-09-30 | 2.925 | 1.504 | 2.569 | No Different than National Benchmark | |
| Central Line Associated Bloodstream Infection: Number of Device Days2024-10-01 to 2025-09-30 | 1,932 | 1,370 | 1,982 | No Different than National Benchmark | |
| Central Line Associated Bloodstream Infection (ICU + select Wards): Predicted Cases2024-10-01 to 2025-09-30 | 1.686 | 0.9835 | 1.874 | No Different than National Benchmark | |
| Central Line Associated Bloodstream Infection (ICU + select Wards): Observed Cases2024-10-01 to 2025-09-30 | 1 | 0 | 1.765 | No Different than National Benchmark | |
| Central Line Associated Bloodstream Infection (ICU + select Wards)2024-10-01 to 2025-09-30 | 0.593 | 0.484 | 0.993 | No Different than National Benchmark | Worse than 60% of US hospitals |
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Lower Confidence Limit2024-10-01 to 2025-09-30 | 0.205 | 0.138 | 0.324 | No Different than National Benchmark | |
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Upper Confidence Limit2024-10-01 to 2025-09-30 | 4.039 | 1.392 | 2.24 | No Different than National Benchmark | |
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Number of Urinary Catheter Days2024-10-01 to 2025-09-30 | 2,412 | 1,799 | 2,391 | No Different than National Benchmark | |
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Predicted Cases2024-10-01 to 2025-09-30 | 1.636 | 1.377 | 2.482 | No Different than National Benchmark | |
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Observed Cases2024-10-01 to 2025-09-30 | 2 | 0 | 1.611 | No Different than National Benchmark | |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)2024-10-01 to 2025-09-30 | 1.222 | 0.399 | 0.5717 | No Different than National Benchmark | Worse than 92% of US hospitals |
| SSI - Colon Surgery: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.5587 | |||
| SSI - Colon Surgery: Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 2.699 | |||
| SSI - Colon Surgery: Number of Procedures2024-10-01 to 2025-09-30 | 9 | 61 | 70.91 | ||
| SSI - Colon Surgery: Predicted Cases2024-10-01 to 2025-09-30 | 0.222 | 1.591 | 1.941 | ||
| SSI - Colon Surgery: Observed Cases2024-10-01 to 2025-09-30 | 0 | 1 | 2.174 | ||
| SSI - Colon Surgery2024-10-01 to 2025-09-30 | Not Available | 0.9397 | |||
| SSI - Abdominal Hysterectomy: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.375 | |||
| SSI - Abdominal Hysterectomy: Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 3.326 | |||
| SSI - Abdominal Hysterectomy: Number of Procedures2024-10-01 to 2025-09-30 | 113 | 38 | 60.63 | ||
| SSI - Abdominal Hysterectomy: Predicted Cases2024-10-01 to 2025-09-30 | 0.984 | 0.328 | 0.5225 | ||
| SSI - Abdominal Hysterectomy: Observed Cases2024-10-01 to 2025-09-30 | 1 | 0 | 0.7368 | ||
| SSI - Abdominal Hysterectomy2024-10-01 to 2025-09-30 | Not Available | 1.221 | |||
| MRSA Bacteremia: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.2613 | No Different than National Benchmark | ||
| MRSA Bacteremia: Upper Confidence Limit2024-10-01 to 2025-09-30 | 1.855 | 1.855 | 2.138 | No Different than National Benchmark | |
| MRSA Bacteremia: Patient Days2024-10-01 to 2025-09-30 | 32,209 | 14,451 | 24,894 | No Different than National Benchmark | |
| MRSA Bacteremia: Predicted Cases2024-10-01 to 2025-09-30 | 1.615 | 0.567 | 1.377 | No Different than National Benchmark | |
| MRSA Bacteremia: Observed Cases2024-10-01 to 2025-09-30 | 0 | 0 | 0.9143 | No Different than National Benchmark | |
| MRSA Bacteremia2024-10-01 to 2025-09-30 | 0 | 0.597 | 0.6371 | No Different than National Benchmark | The best result, shared by 18% of US hospitals |
| Clostridium Difficile (C.Diff): Lower Confidence Limit2024-10-01 to 2025-09-30 | 0.145 | 0.127 | 0.2534 | Better than the National Benchmark | |
| Clostridium Difficile (C.Diff): Upper Confidence Limit2024-10-01 to 2025-09-30 | 0.878 | 0.747 | 1.654 | Better than the National Benchmark | |
| Clostridium Difficile (C.Diff): Patient Days2024-10-01 to 2025-09-30 | 20,111 | 13,646 | 23,022 | Better than the National Benchmark | |
| Clostridium Difficile (C.Diff): Predicted Cases2024-10-01 to 2025-09-30 | 12.63 | 5.683 | 13.68 | Better than the National Benchmark | |
| Clostridium Difficile (C.Diff): Observed Cases2024-10-01 to 2025-09-30 | 5 | 2 | 8.257 | Better than the National Benchmark | |
| Clostridium Difficile (C.Diff)2024-10-01 to 2025-09-30 | 0.396 | 0.279 | 0.5388 | Better than the National Benchmark | Worse than 66% of US hospitals |
How recent inpatients answered each survey question, with CMS's star rating per topic.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Room was "always" clean2024-10-01 to 2025-09-30 · 493 cases | 59 | 73 | 71.79 | Worse than 95% of US hospitals | |
| Room was "sometimes" or "never" clean2024-10-01 to 2025-09-30 · 493 cases | 19 | 8 | 9.364 | Worse than 97% of US hospitals | |
| Room was "usually" clean2024-10-01 to 2025-09-30 · 493 cases | 22 | 18 | 18.85 | ||
| Cleanliness - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 78 | 87 | 85.5 | Worse than 96% of US hospitals | |
| Cleanliness - star rating2024-10-01 to 2025-09-30 · 493 cases | 1 | 4 | 3.154 | The lowest rating, shared by 4% of US hospitals | |
| Nurses "always" communicated well2024-10-01 to 2025-09-30 · 493 cases | 72 | 80 | 78.06 | Worse than 90% of US hospitals | |
| Nurse communication - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 88 | 91 | 90.08 | Worse than 88% of US hospitals | |
| Nurses "sometimes" or "never" communicated well2024-10-01 to 2025-09-30 · 493 cases | 7 | 4 | 4.939 | Worse than 86% of US hospitals | |
| Nurse communication - star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.923 | Worse than 79% of US hospitals | |
| Nurses "usually" communicated well2024-10-01 to 2025-09-30 · 493 cases | 21 | 16 | 17 | ||
| Doctors "always" communicated well2024-10-01 to 2025-09-30 · 493 cases | 72 | 79 | 77.85 | Worse than 91% of US hospitals | |
| Doctor communication - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 87 | 91 | 89.85 | Worse than 90% of US hospitals | |
| Doctors "sometimes" or "never" communicated well2024-10-01 to 2025-09-30 · 493 cases | 8 | 5 | 6.273 | Worse than 84% of US hospitals | |
| Doctor communication - star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.885 | Worse than 71% of US hospitals | |
| Doctors "usually" communicated well2024-10-01 to 2025-09-30 · 493 cases | 20 | 16 | 15.88 | ||
| Staff "always" explained2024-10-01 to 2025-09-30 · 493 cases | 53 | 61 | 61.85 | Worse than 90% of US hospitals | |
| Communication about medicines - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 73 | 77 | 77.19 | Worse than 78% of US hospitals | |
| Staff "sometimes" or "never" explained2024-10-01 to 2025-09-30 · 493 cases | 23 | 19 | 18.55 | Worse than 73% of US hospitals | |
| Communication about medicines - star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.731 | Worse than 53% of US hospitals | |
| Staff "usually" explained2024-10-01 to 2025-09-30 · 493 cases | 24 | 19 | 19.61 | ||
| Discharge information - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 80 | 86 | 82.69 | Worse than 91% of US hospitals | |
| No, staff "did not" give patients this information2024-10-01 to 2025-09-30 · 493 cases | 20 | 13 | 16.3 | Worse than 92% of US hospitals | |
| Discharge information - star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.577 | Worse than 82% of US hospitals | |
| Yes, staff "did" give patients this information2024-10-01 to 2025-09-30 · 493 cases | 80 | 87 | 83.7 | Worse than 92% of US hospitals | |
| No, staff "did not" give patients information about help after discharge2024-10-01 to 2025-09-30 · 493 cases | 22 | 14 | 18.6 | Worse than 91% of US hospitals | |
| Yes, staff "did" give patients information about help after discharge2024-10-01 to 2025-09-30 · 493 cases | 78 | 86 | 81.4 | Worse than 91% of US hospitals | |
| Doctors "always" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 66 | 74 | 73.07 | Worse than 92% of US hospitals | |
| Doctors "sometimes" or "never" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 10 | 7 | 7.8 | Worse than 84% of US hospitals | |
| Doctors "usually" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 24 | 19 | 19.13 | ||
| Doctors "always" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 71 | 77 | 75.67 | Worse than 86% of US hospitals | |
| Doctors "sometimes" or "never" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 9 | 6 | 6.6 | Worse than 86% of US hospitals | |
| Doctors "usually" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 20 | 17 | 17.73 | ||
| Doctors "always" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 78 | 85 | 83.67 | Worse than 92% of US hospitals | |
| Doctors "sometimes" or "never" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 7 | 3 | 4.6 | Worse than 92% of US hospitals | |
| Doctors "usually" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 15 | 11 | 11.73 | ||
| Patients who gave a rating of "6" or lower (low)2024-10-01 to 2025-09-30 · 493 cases | 15 | 8 | 9.758 | Worse than 92% of US hospitals | |
| Patients who gave a rating of "7" or "8" (medium)2024-10-01 to 2025-09-30 · 493 cases | 24 | 20 | 21.24 | ||
| Patients who gave a rating of "9" or "10" (high)2024-10-01 to 2025-09-30 · 493 cases | 61 | 72 | 69 | Worse than 87% of US hospitals | |
| Overall hospital rating - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 83 | 88 | 86.42 | Worse than 90% of US hospitals | |
| Overall hospital rating - star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.885 | Worse than 78% of US hospitals | |
| Staff "always" explained new medications2024-10-01 to 2025-09-30 · 493 cases | 66 | 74 | 73.67 | Worse than 92% of US hospitals | |
| Staff "sometimes" or "never" explained new medications2024-10-01 to 2025-09-30 · 493 cases | 12 | 9 | 9.333 | Worse than 73% of US hospitals | |
| Staff "usually" explained new medications2024-10-01 to 2025-09-30 · 493 cases | 22 | 16 | 17 | ||
| Nurses "always" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 66 | 75 | 72.83 | Worse than 94% of US hospitals | |
| Nurses "sometimes" or "never" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 9 | 5 | 6.8 | Worse than 86% of US hospitals | |
| Nurses "usually" explained things so they could understand2024-10-01 to 2025-09-30 · 493 cases | 25 | 20 | 20.37 | ||
| Nurses "always" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 68 | 77 | 74.7 | Worse than 91% of US hospitals | |
| Nurses "sometimes" or "never" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 7 | 4 | 5.4 | Worse than 81% of US hospitals | |
| Nurses "usually" listened carefully2024-10-01 to 2025-09-30 · 493 cases | 25 | 19 | 19.9 | ||
| Nurses "always" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 81 | 86 | 84.83 | Worse than 83% of US hospitals | |
| Nurses "sometimes" or "never" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 5 | 3 | 3.5 | Worse than 86% of US hospitals | |
| Nurses "usually" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 493 cases | 14 | 11 | 11.67 | ||
| "Always" quiet at night2024-10-01 to 2025-09-30 · 493 cases | 56 | 59 | 60.39 | Worse than 60% of US hospitals | |
| "Sometimes" or "never" quiet at night2024-10-01 to 2025-09-30 · 493 cases | 16 | 9 | 9.03 | Worse than 83% of US hospitals | |
| "Usually" quiet at night2024-10-01 to 2025-09-30 · 493 cases | 28 | 31 | 30.58 | ||
| Quietness - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 79 | 82 | 81.38 | Worse than 66% of US hospitals | |
| Quietness - star rating2024-10-01 to 2025-09-30 · 493 cases | 3 | 3 | 3.269 | Worse than 44% of US hospitals | |
| "NO", patients would not recommend the hospital (they probably would not or definitely would not recommend it)2024-10-01 to 2025-09-30 · 493 cases | 8 | 5 | 6.727 | Worse than 76% of US hospitals | |
| "YES", patients would definitely recommend the hospital2024-10-01 to 2025-09-30 · 493 cases | 65 | 71 | 66.88 | Worse than 73% of US hospitals | |
| Recommend hospital - linear mean score2024-10-01 to 2025-09-30 · 493 cases | 84 | 87 | 84.85 | Worse than 74% of US hospitals | |
| "YES", patients would probably recommend the hospital2024-10-01 to 2025-09-30 · 493 cases | 27 | 23 | 26.39 | ||
| Recommend hospital - star rating2024-10-01 to 2025-09-30 · 493 cases | 3 | 4 | 3.154 | Worse than 58% of US hospitals | |
| Staff "always" explained possible side effects2024-10-01 to 2025-09-30 · 493 cases | 40 | 47 | 50.23 | Worse than 85% of US hospitals | |
| Staff "sometimes" or "never" explained possible side effects2024-10-01 to 2025-09-30 · 493 cases | 35 | 30 | 28.17 | Worse than 74% of US hospitals | |
| Staff "usually" explained possible side effects2024-10-01 to 2025-09-30 · 493 cases | 25 | 22 | 21.6 | ||
| Summary star rating2024-10-01 to 2025-09-30 · 493 cases | 2 | 3 | 2.923 | Worse than 81% of US hospitals | |
| No, staff "did not" give patients information about possible symptoms2024-10-01 to 2025-09-30 · 493 cases | 17 | 12 | 14.17 | Worse than 86% of US hospitals | |
| Yes, staff "did" give patients information about possible symptoms2024-10-01 to 2025-09-30 · 493 cases | 83 | 88 | 85.83 | Worse than 86% of US hospitals |
How often the hospital gave recommended care, and how fast.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Emergency department volume2024-01-01 to 2024-12-31 | medium | ||||
| Global Malnutrition Composite Score2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Malnutrition Diagnosis Documented2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Malnutrition Risk Screening2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Nutrition Assessment2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Nutritional Care Plan2024-01-01 to 2024-12-31 | Not Available | ||||
| Hospital Harm - Severe Hyperglycemia2024-01-01 to 2024-12-31 | Not Available | 7.9 | |||
| Hospital Harm - Severe Hypoglycemia2024-01-01 to 2024-12-31 | Not Available | 1.357 | |||
| Hospital Harm - Opioid Related Adverse Events2024-01-01 to 2024-12-31 | Not Available | 0.08333 | |||
| Healthcare workers given influenza vaccination2024-10-01 to 2025-03-31 · 1,189 cases | 95 | 79 | 71.94 | Better than 86% of US hospitals | |
| Average (median) time all patients spent in the emergency department before leaving from the visit, including psychiatric/mental health patients and patients who were transferred to another facility. A lower number of minutes is better2024-10-01 to 2025-09-30 · 400 cases | 207 | 154 | 176 | Worse than 81% of US hospitals | |
| Average (median) time patients spent in the emergency department before leaving from the visit, excluding patients transferred to another facility or psychiatric care/mental health patients. A lower number of minutes is better2024-10-01 to 2025-09-30 · 376 cases | 205 | 148 | 169 | Worse than 83% of US hospitals | |
| Average (median) time psychiatric/mental health patients spent in the emergency department before leaving from the visit. A lower number of minutes is better2024-10-01 to 2025-09-30 · 16 cases | 178 | 247 | 263 | Better than 77% of US hospitals | |
| Average (median) time patients spent in the emergency department before being transferred to another facility. A lower number of minutes is better2024-10-01 to 2025-09-30 | Not Available | 430 | |||
| Left before being seen2024-01-01 to 2024-12-31 · 27,497 cases | 2 | 1 | 2.6 | Worse than 58% of US hospitals | |
| Head CT results2024-10-01 to 2025-09-30 | Not Available | 54.3 | |||
| Endoscopy/polyp surveillance: appropriate follow-up interval for normal colonoscopy in average risk patients2024-01-01 to 2024-12-31 · 79 cases | 94 | 97 | 87.5 | Worse than 65% of US hospitals | |
| Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery2024-01-01 to 2024-12-31 | Not Available | ||||
| ST-Segment Elevation Myocardial Infarction (STEMI)2024-01-01 to 2024-12-31 | Not Available | 39.4 | |||
| Safe Use of Opioids - Concurrent Prescribing2024-01-01 to 2024-12-31 · 1,624 cases | 7 | 15 | 12.13 | Better than 93% of US hospitals | |
| Appropriate care for severe sepsis and septic shock2024-10-01 to 2025-09-30 · 205 cases | 71 | 65 | 55.07 | Better than 63% of US hospitals | |
| Septic Shock 3-Hour Bundle2024-10-01 to 2025-09-30 · 40 cases | 72 | 73 | 72.04 | Worse than 51% of US hospitals | |
| Septic Shock 6-Hour Bundle2024-10-01 to 2025-09-30 · 24 cases | 92 | 88 | 80.17 | Better than 61% of US hospitals | |
| Severe Sepsis 3-Hour Bundle2024-10-01 to 2025-09-30 · 205 cases | 80 | 82 | 73.64 | Worse than 56% of US hospitals | |
| Severe Sepsis 6-Hour Bundle2024-10-01 to 2025-09-30 · 121 cases | 96 | 94 | 87.68 | Better than 60% of US hospitals | |
| Discharged on Antithrombotic Therapy2024-01-01 to 2024-12-31 · 28 cases | 96 | 98 | 95.63 | Worse than 66% of US hospitals | |
| Anticoagulation Therapy for Atrial Fibrillation/Flutter2024-01-01 to 2024-12-31 | Not Available | ||||
| Antithrombotic Therapy by End of Hospital Day 22024-01-01 to 2024-12-31 | Not Available | 92.2 | |||
| Venous Thromboembolism Prophylaxis2024-01-01 to 2024-12-31 · 1,579 cases | 92 | 90 | 78.24 | Better than 56% of US hospitals | |
| Intensive Care Unit Venous Thromboembolism Prophylaxis2024-01-01 to 2024-12-31 · 545 cases | 96 | 97 | 89.93 | Worse than 55% of US hospitals |
How often scans were ordered when they may not be needed; lower is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Abdomen CT Use of Contrast Material2024-07-01 to 2025-06-30 | 8 | 5 | 6.748 | Worse than 77% of US hospitals | |
| Breast Cancer Screening Recall Rates2024-07-01 to 2025-06-30 | 17.5 | 6.6 | 6.677 | Worse than 95% of US hospitals |
Medicare spending around an inpatient stay compared with the US (1 is the US median).
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Medicare hospital spending per patient (Medicare Spending per Beneficiary)2024-01-01 to 2024-12-31 | 0.99 | 0.99 | 0.9342 | Worse than 47% of US hospitals |
The scores Medicare uses to raise or lower inpatient payments; higher is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| VBP clinical outcomes domain scoreFY 2026 | 45 | 20 | 18.3 | Better than 87% of US hospitals | |
| VBP clinical outcomes weighted domain scoreFY 2026 | 11.25 | 5 | 4.574 | Better than 87% of US hospitals | |
| VBP efficiency and cost reduction domain scoreFY 2026 | 20 | 10 | 39.47 | Better than 57% of US hospitals | |
| VBP efficiency and cost reduction weighted domain scoreFY 2026 | 5 | 2.5 | 10.61 | Better than 57% of US hospitals | |
| VBP person and community engagement domain scoreFY 2026 | 30 | 34 | 29.11 | Worse than 58% of US hospitals | |
| VBP person and community engagement weighted domain scoreFY 2026 | 7.5 | 8.75 | 7.745 | Worse than 58% of US hospitals | |
| VBP safety domain scoreFY 2026 | 72 | 40 | 42.8 | Better than 92% of US hospitals | |
| VBP safety weighted domain scoreFY 2026 | 18 | 10 | 10.77 | Better than 91% of US hospitals | |
| VBP total performance scoreFY 2026 | 41.75 | 29.5 | 32.49 | Better than 83% of US hospitals |
| By fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| VBP clinical outcomes domain score | 15 | 35 | 30 | 10 | 0 | 45 |
| VBP clinical outcomes weighted domain score | 3.75 | 8.75 | 7.5 | 2.5 | 0 | 11.25 |
| VBP efficiency and cost reduction domain score | 20 | Not Available | 30 | 10 | 50 | 20 |
| VBP efficiency and cost reduction weighted domain score | 5 | Not Available | 7.5 | 2.5 | 12.5 | 5 |
| VBP person and community engagement domain score | 13 | Not Available | Not Available | 2 | 7 | 30 |
| VBP person and community engagement weighted domain score | 3.25 | Not Available | Not Available | 0.5 | 1.75 | 7.5 |
| VBP safety domain score | 24 | Not Available | Not Available | 25 | 45 | 72 |
| VBP safety weighted domain score | 6 | Not Available | Not Available | 6.25 | 11.25 | 18 |
| VBP total performance score | 18 | Not Available | Not Available | 11.75 | 25.5 | 41.75 |
Excess readmission ratios by condition; above 1 means more readmissions than expected.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| READM-30-AMI-HRRP2021-07-01 to 2024-06-30 | N/A | 0.9889 | |||
| READM-30-CABG-HRRP2021-07-01 to 2024-06-30 | N/A | 0.9988 | |||
| READM-30-COPD-HRRP2021-07-01 to 2024-06-30 | N/A | 0.9936 | |||
| READM-30-HF-HRRP2021-07-01 to 2024-06-30 | 0.9598 | 0.9983 | 0.9814 | Better than 75% of US hospitals | |
| READM-30-HIP-KNEE-HRRP2021-07-01 to 2024-06-30 | N/A | 0.9733 | |||
| READM-30-PN-HRRP2021-07-01 to 2024-06-30 | 1.005 | 0.9955 | 0.9793 | Worse than 56% of US hospitals |
| By fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| READM-30-AMI-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-CABG-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-COPD-HRRP | 0.9604 | 0.9803 | 0.9802 | N/A | N/A | N/A |
| READM-30-HF-HRRP | 0.9917 | 1.013 | 1.047 | 1.035 | 1.033 | 0.9598 |
| READM-30-HIP-KNEE-HRRP | 1.158 | 0.8711 | 0.8991 | 1.012 | 1.148 | N/A |
| READM-30-PN-HRRP | 0.9498 | 0.9783 | 0.993 | 1.019 | 1.015 | 1.005 |
Infection ratios, the PSI 90 composite and the total score Medicare ranks hospitals on; lower is better.
| Measure | Lovelace Women S Hospital | US median | NM average | CMS comparison | US rank |
|---|---|---|---|---|---|
| CAUTI standardized infection ratio2023-01-01 to 2024-12-31 | 0.62 | 0.489 | 0.5426 | Worse than 63% of US hospitals | |
| CDI standardized infection ratio2023-01-01 to 2024-12-31 | 0.258 | 0.346 | 0.5349 | Better than 64% of US hospitals | |
| CLABSI standardized infection ratio2023-01-01 to 2024-12-31 | 0.585 | 0.559 | 0.4664 | Worse than 53% of US hospitals | |
| HAC Reduction Program payment reductionFY 2026 | No | ||||
| MRSA standardized infection ratio2023-01-01 to 2024-12-31 | 0 | 0.6405 | 0.5306 | The best result, shared by 12% of US hospitals | |
| Patient safety and adverse events composite (PSI 90)2022-07-01 to 2024-06-30 | 0.9202 | 0.9628 | 1.081 | Better than 67% of US hospitals | |
| SSI standardized infection ratio2023-01-01 to 2024-12-31 | 1.303 | 0.7945 | 0.6925 | Worse than 78% of US hospitals | |
| Total HAC scoreFY 2026 | -0.2492 | -0.0453 | 0.3344 | Better than 65% of US hospitals |
| By fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| HAC Reduction Program payment reduction | No | No | N/A | Yes | Yes | No |
| Total HAC score | -0.4166 | -0.059 | 0 | 0.87 | 0.5167 | -0.2492 |
Source: CMS Care Compare hospital files, latest release 2026-09-30, with program results for earlier fiscal years from CMS's archived snapshots. US medians and ranks count every hospital CMS reports; state averages are plain means of the state's reporting hospitals, not CMS's patient-weighted state rates.
The Joint Commission (since 2025)
Accreditation
Limited
Medical school affiliation
Private (for profit)
Ownership type
120
Medicare-certified beds
209
Registered nurses (full-time equivalent)
1966
In Medicare since
Source: CMS Provider of Services file, as reported by the hospital and state surveyors.
What Lovelace Women S Hospital reported to Medicare in its latest cost report, covering May 1, 2024 to Apr 30, 2025.
9,103
Inpatient discharges
Medicare 6%, Medicaid 3%
29,212
Inpatient days
49% of available bed days used
1,140
Employees (full-time equivalent)
1
Interns and residents (full-time equivalent)
Source: CMS cost report (HCRIS) (report 819137). Figures cover the reporting period, which is not always 12 months, and are self-reported.
Inpatient days and discharges Lovelace Women S Hospital reported by payer. Medicare and Medicaid include their managed care plans, shown separately below.
| Medicare | Medicaid | Other | Total | |
|---|---|---|---|---|
| Inpatient days | 2,354 | 689 | 26,169 | 29,212 |
| Discharges | 565 | 269 | 8,269 | 9,103 |
| Average length of stay | 4.2 days | 2.6 days | 3.2 days | 3.2 days |
| Average daily census | 6.4 | 1.9 | 71.7 | 80.0 |
4,066
Medicare Advantage days
870 discharges
14,766
Medicaid managed care days
4,758 discharges
1,137
Observation bed days
| Unit | Beds | Inpatient days | Medicare days | Occupancy |
|---|---|---|---|---|
| Adults & pediatrics | 112 | 17,223 | 2,174 | 42% |
| Intensive care unit | 8 | 919 | 180 | 31% |
| Other special care | 42 | 11,070 | 72% |
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheet S-3 Part I.
What Lovelace Women S Hospital treats Medicare patients for most often, in 2024. 195 Medicare discharges in 10 published DRGs; 19% surgical; 79% in DRGs with complications (CC or MCC).
| Condition or procedure | Discharges | Average charges | Average Medicare payment | Estimated cost | DRG weight |
|---|---|---|---|---|---|
| Septicemia or severe sepsis without MV >96 hours with MCCMS-DRG 871, medical | 58 | $87,351 | $11,099 | $10,307 | 1.98 |
| Simple pneumonia and pleurisy with MCCMS-DRG 193, medical | 23 | $71,150 | $7,576 | $8,396 | 1.33 |
| Heart failure and shock with MCCMS-DRG 291, medical | 19 | $53,610 | $8,262 | $6,326 | 1.28 |
| Respiratory infections and inflammations with MCCMS-DRG 177, medical | 18 | $78,310 | $10,225 | $9,241 | 1.70 |
| Septicemia or severe sepsis without MV >96 hours without MCCMS-DRG 872, medical | 16 | $65,587 | $5,883 | $7,739 | 1.03 |
| Kidney and ureter procedures for non-neoplasm without cc/mccMS-DRG 661, surgical | 14 | $80,260 | $6,114 | $9,471 | 1.05 |
| Kidney and ureter procedures for non-neoplasm with CCMS-DRG 660, surgical | 13 | $89,505 | $8,479 | $10,562 | 1.35 |
| Other kidney and urinary tract diagnoses with MCCMS-DRG 698, medical | 12 | $100,518 | $10,384 | $11,861 | 1.65 |
| Major hip and knee joint replacement or reattachment of lower extremity without MCCMS-DRG 470, surgical | 11 | $128,805 | $12,337 | $15,199 | 1.88 |
| Renal failure with CCMS-DRG 683, medical | 11 | $48,634 | $5,042 | $5,739 | 0.90 |
Source: CMS Medicare Inpatient Hospitals by Provider and Service (2024 data, released 2026-04-10), traditional Medicare only; CMS omits DRGs with fewer than 11 discharges. Estimated cost is average charges times the hospital's Medicare cost-to-charge ratio from the IPPS Impact File. Weights are the MS-DRG relative weights for the same year.
The comprehensive outpatient service groups (APCs) Lovelace Women S Hospital billed Medicare for most in 2024: 1,061 services in all.
| Service group | Services | Patients | Average charges | Average Medicare payment | US average payment |
|---|---|---|---|---|---|
| Level 5 Urology and Related ServicesAPC 5375 | 161 | 156 | $58,363 | $3,557 | $3,918 |
| Level 1 Laparoscopy and Related ServicesAPC 5361 | 137 | 136 | $75,590 | $3,980 | $4,358 |
| Level 1 Nerve ProceduresAPC 5431 | 101 | 87 | $23,633 | $1,362 | $1,407 |
| Level 2 Excision/ Biopsy/ Incision and DrainageAPC 5072 | 92 | 82 | $9,282 | $1,091 | $1,220 |
| Level 5 Musculoskeletal ProceduresAPC 5115 | 78 | 76 | $96,923 | $9,742 | $10,772 |
| Level 2 Laparoscopy and Related ServicesAPC 5362 | 59 | 59 | $100,803 | $7,221 | $8,164 |
| Level 4 Urology and Related ServicesAPC 5374 | 55 | 51 | $39,111 | $2,413 | $2,629 |
| Level 1 Breast/Lymphatic Surgery and Related ProceduresAPC 5091 | 54 | 52 | $48,377 | $2,688 | $2,930 |
| Level 4 Gynecologic ProceduresAPC 5414 | 52 | 52 | $39,578 | $2,162 | $2,389 |
| Comprehensive Observation ServicesAPC 8011 | 46 | 45 | $26,848 | $1,929 | $2,090 |
See all 21 Medicare outpatient services at Lovelace Women S Hospital
Source: CMS Medicare Outpatient Hospitals by Provider and Service (2024 data, released 2026-06-24), comprehensive APCs for traditional Medicare; CMS omits services with fewer than 11 claims. The US average weights every hospital by its services.
ZIP codes with the most Medicare inpatient stays at Lovelace Women S Hospital in 2025. Market share is this hospital's part of every hospital's Medicare stays from the ZIP code. Its published Medicare stays went from 1,197 in 2020 to 1,199 in 2025.
| ZIP code | Stays | Of this hospital's stays | Days | Charges | Market share | Share in 2020 |
|---|---|---|---|---|---|---|
| 87111 | 182 | 15% | 790 | $17.1M | 8% | 9% |
| 87109 | 178 | 15% | 728 | $15.7M | 9% | 12% |
| 87110 | 101 | 8% | 481 | $11.2M | 6% | 9% |
| 87112 | 99 | 8% | 388 | $8.3M | 5% | 6% |
| 87107 | 82 | 7% | 337 | $7.7M | 6% | 7% |
| 87123 | 79 | 7% | 303 | $7.1M | 5% | 4% |
| 87114 | 46 | 4% | 214 | $5.3M | 2% | 3% |
| 87108 | 43 | 4% | 182 | $4.1M | 3% | 3% |
| 87113 | 42 | 4% | 186 | $3.8M | 9% | 9% |
| 87124 | 40 | 3% | 205 | $5M | 2% | 2% |
| 87105 | 39 | 3% | 180 | $4.6M | 2% | 3% |
| 87120 | 36 | 3% | 128 | $3.6M | 2% | 2% |
| 87122 | 31 | 3% | 122 | $3.1M | 5% | 5% |
| 87002 | 27 | 2% | 102 | $2.5M | 3% | 2% |
| 87121 | 21 | 2% | 79 | $2.2M | 1% | 2% |
| 87031 | 18 | 2% | 73 | $1.9M | 1% | 3% |
| 87144 | 18 | 2% | 83 | $2.4M | 1% | 2% |
| 87004 | 14 | 1% | 51 | $1.1M | 3% | 4% |
| 87015 | 14 | 1% | 59 | $1.4M | 3% | 4% |
| 87104 | 14 | 1% | 76 | $1.8M | 2% | 2% |
| 87701 | 14 | 1% | 67 | $1.6M | 2% | |
| 87020 | 13 | 1% | 51 | $1.1M | 4% | |
| 87106 | 13 | 1% | 64 | $1.5M | 2% | 3% |
| 87047 | 12 | 1% | 40 | $963,873 | 6% | |
| 87102 | 12 | 1% | 53 | $1.7M | 1% | 3% |
Source: CMS Hospital Service Area file. Shares are of the 1,199 stays from ZIP codes CMS publishes; it omits ZIP codes with fewer than 11 stays, so market shares count published stays only.
Staff by profession and the rooms and units Lovelace Women S Hospital reported at its latest Medicare certification survey (2024). Counts are people, not full-time equivalents.
7
Operating rooms
2
Endoscopy rooms
1
Off-site locations
209
Registered nurses
10
Licensed practical nurses
9
Pharmacists
11
Respiratory therapists
10
Physical therapists
5
Occupational therapists
11
Radiology technicians
2
Nuclear medicine technicians
533
Other personnel
Source: CMS Provider of Services file.
443 clinicians who bill Medicare list Lovelace Women S Hospital as a hospital affiliation. Showing 24 of them. Book a demo to see the commercial rates insurers publish for them, or start a free trial.
Jacqueline Dean, MD
Rheumatology Physician
NPI 1184690364
See commercial rates for Jacqueline Dean, MDKader Abdelerahman, M.D.
Neurology Physician
NPI 1003058157
See commercial rates for Kader Abdelerahman, M.D.Masoud Shiehmorteza, M.D.
Diagnostic Radiology Physician
NPI 1164724449
See commercial rates for Masoud Shiehmorteza, M.D.Ketura Wisner, D.O.
Gynecologic Oncology Physician
NPI 1205147592
See commercial rates for Ketura Wisner, D.O.Karen Finkelstein, MD
Gynecologic Oncology Physician
NPI 1881643989
See commercial rates for Karen Finkelstein, MDSofia Palacio Cardenas, M.D.
Hematology & Oncology Physician
NPI 1063776086
See commercial rates for Sofia Palacio Cardenas, M.D.Katherine Sanchez, MD
Medical Oncology Physician
NPI 1558740647
See commercial rates for Katherine Sanchez, MDPaul Brittain, MD
Hematology & Oncology Physician
NPI 1184980989
See commercial rates for Paul Brittain, MDAnnette Fontaine, MD
Medical Oncology Physician
NPI 1346234788
See commercial rates for Annette Fontaine, MDMuhammad Tarakji, MD
Hematology & Oncology Physician
NPI 1750497863
See commercial rates for Muhammad Tarakji, MDJoshu Raiten, M.D.
Pain Medicine (Physical Medicine & Rehabilitation) Physician
NPI 1154565539
See commercial rates for Joshu Raiten, M.D.Vanessa Licona Sanjuan, MD
Neurology Physician
NPI 1386958825
See commercial rates for Vanessa Licona Sanjuan, MDRobbie Shoots, MD
Diagnostic Radiology Physician
NPI 1639305378
See commercial rates for Robbie Shoots, MDCraig Nairn, M.D.
Interventional Pain Medicine Physician
NPI 1669495834
See commercial rates for Craig Nairn, M.D.Malcolm Purdy, M.D.
Specialist
NPI 1679535827
See commercial rates for Malcolm Purdy, M.D.Nishiena Gandhi, M.D.
Neurology Physician
NPI 1669527438
See commercial rates for Nishiena Gandhi, M.D.Benjamin Knepper, M.D.
Diagnostic Radiology Physician
NPI 1972620730
See commercial rates for Benjamin Knepper, M.D.Yaw Adjei-Poku, M.D.
Clinical Cardiac Electrophysiology Physician
NPI 1386872745
See commercial rates for Yaw Adjei-Poku, M.D.Michael Bestawros
Clinical Cardiac Electrophysiology Physician
NPI 1699909879
See commercial rates for Michael BestawrosMichael Hoskins, M.D.
Clinical Cardiac Electrophysiology Physician
NPI 1386671766
See commercial rates for Michael Hoskins, M.D.Alan Osumi, MD
Diagnostic Radiology Physician
NPI 1831143247
See commercial rates for Alan Osumi, MDErik Insko, M.D.
Diagnostic Radiology Physician
NPI 1770550667
See commercial rates for Erik Insko, M.D.Sean Mazer, MD
Clinical Cardiac Electrophysiology Physician
NPI 1821025545
See commercial rates for Sean Mazer, MDAndrew Mills, MD
Diagnostic Radiology Physician
NPI 1407072150
See commercial rates for Andrew Mills, MDSource: CMS Doctors and Clinicians facility affiliations, released 2026-10-15, with names and specialties from NPPES. Affiliation means the clinician bills Medicare for care at this hospital; it is not employment.
Revenue, expenses and income Lovelace Women S Hospital reported to Medicare for May 1, 2024 to Apr 30, 2025. Percentages are of net patient revenue.
| Line | Amount | Share |
|---|---|---|
| Gross patient revenue (charges) | $1.4B | 583.4% |
| Inpatient | $665M | 274.2% |
| Outpatient | $749.8M | 309.2% |
| Contractual allowances and discounts | -$1.2B | -483.4% |
| Net patient revenue | $242.5M | 100.0% |
| Operating expenses | -$199.9M | -82.4% |
| Operating income from patient care | $42.6M | 17.6% |
| Other income | $11.8M | 4.9% |
| Net income | $54.4M | 22.4% |
| Line | Amount | Share |
|---|---|---|
| Traditional Medicare | $143.5M | 10.2% |
| Medicaid (including managed care) | $501.8M | 35.6% |
| Other payers and self-pay | $764.2M | 54.2% |
| Total charges | $1.4B | 100.0% |
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Traditional Medicare is the program charges on Worksheets D-3 and D Part V; Medicaid is from Worksheet S-10.
Computed from Lovelace Women S Hospital's latest cost report.
17.6%
Operating margin
Operating income from patient care / net patient revenue
21.4%
Total margin
Net income / net patient revenue plus other income
33.7%
EBITDAR margin
Net income before interest, depreciation and leases (Worksheet A-7), / total revenue
32% of expenses
Personnel costs
Salaries, direct-care contract labor and core wage-related costs / operating expenses
$21.56
Average hourly wage
Adjusted salaries / paid hours (Worksheet S-3 Part II)
67.0%
Return on assets
Net income for a year / total assets
17.7%
Return on equity
Net income for a year / fund balance
3.73
Current ratio
Current assets / current liabilities
2.10
Quick ratio
Cash, temporary investments and net receivables / current liabilities
0 days
Days cash on hand
Cash and temporary investments / daily operating expenses excluding depreciation
49 days
Days in patient receivables
Net patient receivables / daily net patient revenue
29 days
Average payment period
Current liabilities / daily operating expenses excluding depreciation
3.13
Asset turnover
Total revenue for a year / total assets
4.3 years
Average age of plant
Accumulated depreciation / depreciation for a year
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
What Lovelace Women S Hospital owned and owed at the end of its reporting period (Apr 2025), across all fund types: $81.2M in total assets and a $306.8M fund balance.
| Line | Amount | Of total assets |
|---|---|---|
| Cash and temporary investments | $38,266 | 0.0% |
| Patient receivables, net | $32.6M | 40.1% |
| Inventory | $2.4M | 2.9% |
| Total current assets | $57.9M | 71.3% |
| Property and equipment, net of depreciation | $23.3M | 28.7% |
| Investments and other assets | $2,052 | 0.0% |
| Total assets | $81.2M | 100.0% |
| Current liabilities | $15.5M | 19.1% |
| Total liabilities | -$225.6M | -277.8% |
| Fund balance (net assets) | $306.8M | 377.8% |
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Care Lovelace Women S Hospital provided without full payment, as reported on Worksheet S-10 of its cost report.
$2.3M
Cost of charity care
Care for patients approved for charity care and uninsured discounts, at cost
$6.7M
Bad debt
Patient bills written off as uncollectible, at charges
-$6.8M
Medicaid shortfall
Cost of Medicaid patients (charges times the cost-to-charge ratio) minus Medicaid payments; negative means a surplus
$3.1M
Total unreimbursed and uncompensated care
1.5% of operating expenses
Medicaid, CHIP and indigent care shortfalls plus charity care and the cost of bad debt (Worksheet S-10 line 31)
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Lovelace Women S Hospital's full-year cost reports, by fiscal year end. Reports shorter than ten months are left out.
| Fiscal year ending | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 |
|---|---|---|---|---|---|---|
| Net patient revenue | $188M | $205.4M | $195.4M | $198.8M | $205.8M | $242.5M |
| Operating expenses | $161.8M | $181.4M | $178.7M | $183.2M | $181.1M | $199.9M |
| Operating margin | 13.9% | 11.7% | 8.5% | 7.9% | 12.0% | 17.6% |
| Net income | $34.7M | $37.3M | $21.3M | $19.7M | $28.6M | $54.4M |
| Total assets | $31.7M | $33M | $35.2M | $41M | $54.9M | $81.2M |
| Discharges | 6,937 | 7,346 | 6,840 | 6,799 | 6,288 | 9,103 |
| Inpatient days | 31,647 | 32,773 | 31,845 | 30,385 | 28,445 | 29,212 |
| Medicare Advantage days | 3,544 | 3,267 | 3,811 | 4,190 | 3,423 | 4,066 |
| Beds | 162 | 160 | 160 | 162 | 162 | 162 |
| Employees (FTE) | 654 | 601 | 625 | 558 | 545 | 1,140 |
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Each cost center Lovelace Women S Hospital reports, largest first. Total cost includes its share of overhead; the cost-to-charge ratio is total cost / charges.
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Delivery room & labor room | $6.6M | $23.6M | $47.5M | 0.50 | 30,154 |
| Operating room | $6.2M | $21.4M | $513.5M | 0.04 | 19,640 |
| Medical supplies charged to patient | $14.6M | $36.8M | 0.40 | ||
| Radiology-diagnostic | $4.1M | $13.7M | $102.2M | 0.13 | 15,722 |
| Laboratory | $10M | $122.7M | 0.08 | 3,098 | |
| Drugs charged to patients | $9.2M | $61M | 0.15 | ||
| Emergency | $2.8M | $8.7M | $80.4M | 0.11 | 6,753 |
| Impl. dev. charged to patients | $6.8M | $22.6M | 0.30 | ||
| Physical therapy | $1.6M | $3M | $18.7M | 0.16 | |
| Respiratory therapy | $1M | $2.5M | $15.2M | 0.16 | 1,701 |
| Ct scan | $897,493 | $2.2M | $66.2M | 0.03 | 906 |
| Occupational therapy | $536,108 | $979,598 | $7.2M | 0.14 | |
| Observation beds (non-distinct part | $942,198 | $6.3M | 0.15 | ||
| Speech pathology | $26,908 | $47,976 | $493,509 | 0.10 |
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Neonatal intensive care unit | $5.6M | $28.7M | $193.1M | 0.15 | 37,837 |
| Adults & pediatrics | $8.6M | $15.2M | $103M | 0.15 | 7,595 |
| Intensive care unit | $1.4M | $5M | $12.6M | 0.39 | 4,898 |
| Department | Salaries | Direct cost | Paid hours | Average hourly wage | Square feet |
|---|---|---|---|---|---|
| Administrative & general | $3.3M | $48.1M | 53,163 | $61.99 | 14,031 |
| Cap rel costs-bldg & fixt | $26.1M | 239,529 | |||
| Cap rel costs-mvble equip | $5.8M | ||||
| Operation of plant | $1.2M | $3.3M | 77,761 | $15.71 | 41,717 |
| Cafeteria | $2.9M | 3 | $15.56 | 2,402 | |
| Pharmacy | $2.1M | $2.6M | 61,473 | $33.80 | 1,785 |
| Housekeeping | $2.1M | 646 | |||
| Employee benefits department | $740,989 | $1.5M | 17,846 | $41.52 | 1,537 |
| Nursing administration | $819,781 | $1.1M | 39,586 | $20.71 | 2,024 |
| Central services & supply | $623,290 | $856,025 | 46,951 | $13.28 | 2,453 |
| Laundry & linen service | $611,424 | ||||
| Dietary | $48 | $451,503 | 0 | $13.95 | 2,707 |
| I&r services-salary & fringes apprv | $151,449 | ||||
| Medical records & library | $42,309 |
Source: CMS cost report (HCRIS, Form 2552-10), report 819137, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheets A, B-1, C Part I and S-3 Part II.
The factors Medicare uses to set what it pays Lovelace Women S Hospital for an inpatient stay.
1.62
Case mix index
Higher than 42% of hospitals paid under Medicare IPPS
Average Medicare DRG weight of its inpatient cases (FY 2027); higher means more complex, costlier care.
Teaching hospital
Teaching status
0.01 residents per bed
Medicare-funded interns and residents per bed (FY 2027).
57.8%
Low-income patient share
Disproportionate share percentage: Medicaid and SSI patient days CMS uses for safety-net payments (FY 2027).
562
Medicare inpatient stays
Medicare claims CMS based FY 2027 payment rates on.
Urban (metro area)
Location type
Geographic area CMS assigns before any wage index reclassification (FY 2027).
| IPPS fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | FY 2027 |
|---|---|---|---|---|---|---|---|
| Case mix index | 1.53 | 1.53 | 1.58 | 1.61 | 1.53 | 1.58 | 1.62 |
| Wage index | 0.884 | 0.889 | 0.922 | 0.907 | 0.916 | 0.948 | 0.923 |
| Readmissions adjustment | -2.07% | -1.20% | -0.03% | -0.10% | -0.25% | -0.45% | -0.05% |
| Value-based purchasing adjustment | -0.32% | -0.84% | -0.84% | +0.43% | -0.89% | +0.28% | +0.88% |
| Medicare inpatient stays | 719 | 719 | 565 | 606 | 623 | 550 | 562 |
Source: CMS IPPS final rule Impact File (FY 2027).
Organizations Lovelace Women S Hospital reports to Medicare as owners or with operational control.
Ahp Health Partners, Inc
5% or greater indirect ownership interest, 100%, since 2019
Ahs Management Company Inc.
Operational/managerial control, 100%, since 2019
Ardent Health Inc
5% or greater indirect ownership interest, 100%, since 2019
Ardent Legacy Holdings LLC
5% or greater direct ownership interest, 100%, since 2019
Sources: CMS Hospital All Owners.
The officers and board members on Lovelace Women S Hospital's Medicare enrollment and on the IRS Form 990 filed under its tax ID.
Source: CMS Hospital All Owners (PECOS), the people the hospital lists on its Medicare enrollment; the first 4 of 6 are shown.
About Lovelace Women S Hospital's rates and hospital price transparency.
For CT abdomen and pelvis with contrast (CPT 74177), published negotiated rates at Lovelace Women S Hospital range from $824 to $6,163 across 3 insurers. UnitedHealthcare's rate is $824. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Colonoscopy with biopsy (CPT 45380), published negotiated rates at Lovelace Women S Hospital range from $1,629 to $3,548 across 4 insurers. Blue Cross Blue Shield's rate is $1,629. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Vaginal delivery, hospital stay (MS-DRG 807), published negotiated rates at Lovelace Women S Hospital range from $8,805 to $10,412 across 3 insurers. Blue Cross Blue Shield's rate is $9,344. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Screening mammography, bilateral (CPT 77067), published negotiated rates at Lovelace Women S Hospital range from $192 to $393 across 3 insurers. UnitedHealthcare's rate is $204. What a patient pays depends on their plan's deductible, coinsurance and network status.
Lovelace Women S Hospital has a CMS overall hospital star rating of 4 out of 5 on Medicare Care Compare (CMS data released 2026-08-13). That is higher than 58% of US hospitals.
Yes. CMS counts 0.01 Medicare-funded residents per bed at Lovelace Women S Hospital for fiscal year 2027, so it is a teaching hospital.
Yes. Under the Hospital Readmissions Reduction Program, Medicare cuts Lovelace Women S Hospital's base inpatient payments by an estimated 0.05% in fiscal year 2027 for more readmissions than expected.
In 2024, the most common were septicemia or severe sepsis without mv >96 hours with mcc (58 discharges), simple pneumonia and pleurisy with mcc (23 discharges), heart failure and shock with mcc (19 discharges).
Lovelace Women S Hospital's Medicare case mix index is 1.62 for fiscal year 2027, higher than 42% of hospitals paid under the inpatient prospective payment system.
Lovelace Women S Hospital reported 9,103 inpatient discharges and 29,212 inpatient days from May 1, 2024 to Apr 30, 2025.
Lovelace Women S Hospital reported 1,140 full-time-equivalent employees on payroll from May 1, 2024 to Apr 30, 2025.
Lovelace Women S Hospital reported $242.5M in net patient revenue on $1.4B of gross charges for May 1, 2024 to Apr 30, 2025, an operating margin of 17.6%, and net income of $54.4M.
Lovelace Women S Hospital reported $3.1M of unreimbursed and uncompensated care for May 1, 2024 to Apr 30, 2025, including $2.3M of charity care at cost.
Lovelace Women S Hospital's Medicare enrollment lists Matt Maxfield as President And CEO since 2022.
Insurers' price transparency files list Lovelace Women S Hospital under employer identification number 85-0327237 (Lovelace Regional Hospital-Roswell). 49 health plans and networks list 85-0327237 for it.
443 clinicians who bill Medicare list Lovelace Women S Hospital as a hospital affiliation in CMS's Doctors and Clinicians data. The largest groups are family nurse practitioner (58), certified registered nurse anesthetist (47), family medicine physician (37).
Yes. CMS's Provider of Services file lists The Joint Commission as the accrediting organization for Lovelace Women S Hospital, effective 2025.
In its Medicare enrollment, Lovelace Women S Hospital reports Ahp Health Partners, Inc as 5% or greater indirect ownership interest (100%).
CMS lists 31 services at Lovelace Women S Hospital, including Acute Renal Dialysis, Anesthesia, Audiology, CARF Inpatient Rehabilitation (Commission On Accreditation Of Rehabilitation Facilities Inpatient Rehabilitation), Clinical Laboratory, CT Scan.
In CMS's 2025 Hospital Service Area file, the most Medicare inpatient stays at Lovelace Women S Hospital came from ZIP codes 87111 (182), 87109 (178), 87110 (101).
Lovelace Women S Hospital has 162 beds, including its psychiatric, rehabilitation and other subprovider units, in its latest Medicare cost report. 120 are Medicare-certified beds in CMS's Provider of Services file. Facility type: Short Term Acute Care Hospital.
Lovelace Women S Hospital is located at 4701 Montgomery Boulevard Ne, Albuquerque, NM 87109. Its main phone number is (505) 727-7805.
Lovelace Women S Hospital's CMS Certification Number (CCN), also called its Medicare provider number, is 320017.
The National Provider Identifier (NPI) on file for Lovelace Women S Hospital is 1982799375.
Lovelace Women S Hospital is affiliated with Ardent Health Services.
Lovelace Women S Hospital lists 33 in-network payers, including Aetna, Ameri Health, Aspirus Health Plan, Avera Health Plans, and is Medicare-certified. Insurance acceptance may vary by plan, so confirm coverage with your insurer or the hospital's billing department.
271 disclosed rate categories. Each shows the payer, category, code type and group with its code range, and contract type, along with how the rate compares with the state average.
Under 45 CFR Part 180, every US hospital must publish a machine-readable file of its standard charges, including gross charges, discounted cash prices and payer-specific negotiated rates, in the CMS template format. PayerPrice can help hospitals publish and maintain these files.
A chargemaster (charge description master, or CDM) is a hospital's master list of billable items, with codes, descriptions and gross charges. A chargemaster review looks at those lines for accuracy and pricing. PayerPrice can help hospitals review their chargemaster; contact us to discuss your needs.
For hospital finance and compliance teams
The data on this page comes from the files hospitals and payers publish. We help hospitals publish theirs correctly, and take a fresh look at their chargemaster.
We turn your chargemaster and payer contracts into the CMS template file, then keep it current as rates change.
{
"description": "MRI of brain (no contrast)",
"code_information": [
{ "code": "611", "type": "RC" },
{ "code": "70551", "type": "CPT" }
],
"standard_charges": [{
"setting": "outpatient",
"minimum": 250,
"maximum": 400,
"gross_charge": 1200,
"discounted_cash": 1080,
"payers_information": [
{
"payer_name": "Platform Health Insurance",
"plan_name": "PPO",
"methodology": "fee schedule",
"standard_charge_dollar": 400
},
{
"payer_name": "Region Health Insurance",
"plan_name": "HMO",
"methodology": "fee schedule",
"standard_charge_dollar": 250
}
]
}]
}Your chargemaster sets the gross charge on every claim, and many payer contracts base payment on it through percent-of-charge, lesser-of and stop-loss terms. We audit it line by line and show how your charges and negotiated rates compare with peer hospitals before your next negotiation.
What a review covers